Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort studyÓskar Hálfdánarson, Helga Zoëga, Mette Nørgaard et al.|Evidence-Based Mental Health|2021Cited by 28
A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS)Jacqueline M. Cohen, Vidar Hjellvik, Carolyn E. Cesta et al.|Norsk Epidemiologi|2021Cited by 25
Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort studyClaudia Bruno, Helga Zoëga, Carolyn E. Cesta et al.|EClinicalMedicine|2024Cited by 11
Corrigendum to Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study [eClinicalMedicine 70 (2024) 102531/DOI: 10.1016/j.eclinm.2024.102531]Claudia Bruno, Helga Zoëga, Carolyn E. Cesta et al.|EClinicalMedicine|2025Cited by 4
Antipsychotic Use During Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort StudyClaudia Bruno, Helga Zoëga, Carolyn E. Cesta et al.|SSRN Electronic Journal|2023Cited by 2